IPO - Profile

Spindletop Health Acquisition Corp.

Finance > Banks



Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$10.00 20,000,000 Positive High 90.51%

Offering Team

  • Legal counsel
  • DLA Piper LLP
  • Auditors
  • Marcum LLP

Deal Highlights

We are a newly-incorporated blank check company incorporated on February 17, 2021 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not identified any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We will seek to capitalize on the more than 200+ years of combined healthcare experience of our executive team, special advisors and board of directors. We believe our team’s distinctive and complementary backgrounds can have a transformative impact on a target healthcare business. Although we may pursue an acquisition opportunity in any business industry, sector or geographical location, we intend to focus our investment efforts broadly across the entire healthcare and healthcare-related industries in the United States, with an emphasis on healthcare services, healthcare information technology, insurance and related products, biotechnology, pharmaceuticals, medical devices, and diagnostics. Our strategy will be to identify, acquire and, after our initial business combination, build a healthcare or healthcare-related business. Investment opportunities will be sourced through the team’s proprietary and differentiated network, built over decades of investing in, operating and growing healthcare businesses. The company will employ a disciplined and highly-selective investment process that focuses on accessing differentiated opportunities through deep relationships with executives, advisors and intermediaries to enhance the growth potential and value of a target business and provide opportunities for an attractive return to our stockholders.

Deal Tracker

IPO Dates

Filing 03 Nov, 2021

Offer 04 Nov, 2021

Look Ahead

Lock Up Expiry May 04, 2022

IPO Terms

Offer Price $10.00
Offer Size 20M

Market Sentiments

Stock Price